{"doc_id": "PMID-9756417.txt", "sent_id": "S1", "tokens": ["Transcription", "factor", "activation", "in", "lymphokine", "activated", "killer", "cells", "and", "lymphocytes", "from", "patients", "receiving", "IL-2", "immunotherapy", "."], "sentence": "Transcription factor activation in lymphokine activated killer cells and lymphocytes from patients receiving IL-2 immunotherapy .", "event_mentions": [], "entity_mentions": [{"id": "T1", "text": "IL-2", "entity_type": "Protein", "start": 13, "end": 13}]}
{"doc_id": "PMID-9756417.txt", "sent_id": "S2", "tokens": ["Administration", "of", "the", "cytokine", "interleukin-2", "(", "IL-2", ")", "can", "result", "in", "therapeutic", "benefits", "for", "individuals", "with", "renal", "cell", "carcinoma", "and", "melanoma", "."], "sentence": "Administration of the cytokine interleukin-2 ( IL-2 ) can result in therapeutic benefits for individuals with renal cell carcinoma and melanoma .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "interleukin-2", "entity_type": "Protein", "start": 4, "end": 4}, {"id": "T3", "text": "IL-2", "entity_type": "Protein", "start": 6, "end": 6}]}
{"doc_id": "PMID-9756417.txt", "sent_id": "S3", "tokens": ["Here", "we", "report", "an", "analysis", "of", "the", "transcription", "factor", "families", "AP-1", ",", "Sp1", ",", "NF-kappaB", ",", "and", "signal", "transducers", "and", "activators", "of", "transcription", "(", "STAT", ")", "in", "cancer", "patients", "'", "lymphocytes", "before", "and", "after", "IL-2", "immunotherapy", ",", "as", "assessed", "by", "a", "gel-shift", "assay", "."], "sentence": "Here we report an analysis of the transcription factor families AP-1 , Sp1 , NF-kappaB , and signal transducers and activators of transcription ( STAT ) in cancer patients ' lymphocytes before and after IL-2 immunotherapy , as assessed by a gel-shift assay .", "event_mentions": [], "entity_mentions": [{"id": "T4", "text": "Sp1", "entity_type": "Protein", "start": 12, "end": 12}, {"id": "T5", "text": "IL-2", "entity_type": "Protein", "start": 34, "end": 34}]}
{"doc_id": "PMID-9756417.txt", "sent_id": "S4", "tokens": ["An", "in", "vitro", "surrogate", "of", "IL-2", "immunotherapy", "is", "the", "incubation", "of", "fresh", "peripheral", "blood", "mononuclear", "cells", "(", "PBMC", ")", "from", "healthy", "individuals", "in", "IL-2", "for", "several", "days", ",", "resulting", "in", "the", "production", "of", "lymphokine", "-", "activated", "killer", "(", "LAK", ")", "activity", "in", "these", "cultures", "."], "sentence": "An in vitro surrogate of IL-2 immunotherapy is the incubation of fresh peripheral blood mononuclear cells ( PBMC ) from healthy individuals in IL-2 for several days , resulting in the production of lymphokine - activated killer ( LAK ) activity in these cultures .", "event_mentions": [], "entity_mentions": [{"id": "T6", "text": "IL-2", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T7", "text": "IL-2", "entity_type": "Protein", "start": 23, "end": 23}]}
{"doc_id": "PMID-9756417.txt", "sent_id": "", "tokens": ["One", "purpose", "of", "this", "study", "was", "to", "describe", "the", "profile", "of", "transcription", "factor", "activation", "in", "these", "different", "populations", ",", "and", "assess", "whether", "the", "patterns", "observed", "correlated", "with", "functional", "differences", "in", "these", "cells", "."], "sentence": "One purpose of this study was to describe the profile of transcription factor activation in these different populations , and assess whether the patterns observed correlated with functional differences in these cells .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-9756417.txt", "sent_id": "S6", "tokens": ["Prior", "to", "in", "vivo", "IL-2", "administration", ",", "the", "typical", "binding", "pattern", "of", "transcription", "factors", "in", "PBMC", "from", "patients", "resembled", "that", "seen", "in", "fresh", "PBMC", "from", "healthy", "individuals", "."], "sentence": "Prior to in vivo IL-2 administration , the typical binding pattern of transcription factors in PBMC from patients resembled that seen in fresh PBMC from healthy individuals .", "event_mentions": [], "entity_mentions": [{"id": "T8", "text": "IL-2", "entity_type": "Protein", "start": 4, "end": 4}]}
{"doc_id": "PMID-9756417.txt", "sent_id": "S7", "tokens": ["Over", "a", "3-week", "course", "of", "IL-2", "therapy", ",", "in", "most", "patients", "the", "binding", "patterns", "of", "AP-1", ",", "Sp1", ",", "and", "NF-kappaB", "proteins", "changed", "to", "resemble", "those", "seen", "in", "PBMC", "activated", "by", "IL-2", "in", "vitro", "."], "sentence": "Over a 3-week course of IL-2 therapy , in most patients the binding patterns of AP-1 , Sp1 , and NF-kappaB proteins changed to resemble those seen in PBMC activated by IL-2 in vitro .", "event_mentions": [{"id": "E1", "event_type": "Binding", "trigger": {"text": "binding", "start": 12, "end": 12}, "arguments": [{"entity_id": "T10", "text": "Sp1", "role": "Theme"}]}, {"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "changed", "start": 22, "end": 22}, "arguments": [{"entity_id": "T16", "text": "binding", "role": "Theme"}, {"entity_id": "T9", "text": "IL-2", "role": "Cause"}]}], "entity_mentions": [{"id": "T9", "text": "IL-2", "entity_type": "Protein", "start": 5, "end": 5}, {"id": "T10", "text": "Sp1", "entity_type": "Protein", "start": 17, "end": 17}, {"id": "T11", "text": "IL-2", "entity_type": "Protein", "start": 31, "end": 31}, {"id": "T16", "text": "binding", "entity_type": "Binding", "start": 12, "end": 12}, {"id": "T17", "text": "changed", "entity_type": "Positive_regulation", "start": 22, "end": 22}]}
{"doc_id": "PMID-9756417.txt", "sent_id": "S8", "tokens": ["However", ",", "the", "cells", "obtained", "from", "IL-2", "-", "treated", "patients", "did", "not", "have", "low", "-", "level", "constitutive", "expression", "of", "STAT", "binding", "factors", "as", "did", "LAK", "cells", "."], "sentence": "However , the cells obtained from IL-2 - treated patients did not have low - level constitutive expression of STAT binding factors as did LAK cells .", "event_mentions": [], "entity_mentions": [{"id": "T12", "text": "IL-2", "entity_type": "Protein", "start": 6, "end": 6}]}
{"doc_id": "PMID-9756417.txt", "sent_id": "S9", "tokens": ["When", "these", "patient", "cells", "were", "further", "stimulated", "by", "IL-2", "in", "vitro", ",", "additional", "differences", "in", "STAT", "induction", "patterns", "were", "noted", "."], "sentence": "When these patient cells were further stimulated by IL-2 in vitro , additional differences in STAT induction patterns were noted .", "event_mentions": [], "entity_mentions": [{"id": "T13", "text": "IL-2", "entity_type": "Protein", "start": 8, "end": 8}]}
{"doc_id": "PMID-9756417.txt", "sent_id": "S10", "tokens": ["These", "data", "provide", "further", "information", "on", "the", "molecular", "events", "occurring", "in", "immune", "cells", "generated", "through", "in", "vivo", "and", "in", "vitro", "administration", "of", "IL-2", ",", "and", "further", "document", "that", "there", "is", "not", "a", "precise", "congruence", "between", "PBMC", "activated", "in", "vivo", "and", "in", "vitro", "by", "IL-2", "."], "sentence": "These data provide further information on the molecular events occurring in immune cells generated through in vivo and in vitro administration of IL-2 , and further document that there is not a precise congruence between PBMC activated in vivo and in vitro by IL-2 .", "event_mentions": [], "entity_mentions": [{"id": "T14", "text": "IL-2", "entity_type": "Protein", "start": 22, "end": 22}, {"id": "T15", "text": "IL-2", "entity_type": "Protein", "start": 43, "end": 43}]}
